• My Account
  • Cart

Act Missouri

Act Missouri

stars
Taking ACTion to Build a Healthy Missouri
  • Home
  • Blog
  • About
    • Mission, Vision, and Ways We Can Help
    • Staff and Board of Directors
    • Archived Newsletters
    • Programs, Partnerships, and Alliances
    • Contact Us
    • Prevention Resource Center Locator
  • Resources
  • Advocacy
    • Distracted Driving Legislation
    • Prevention Stories
    • Capitol Basics
  • Caring Adults
    • Prevention Emeritus Awards
    • Community Coalitions
    • Prevention Resource Center Locator
  • PRCs
    • Mini Grants
    • Community Coalitions
  • Youth
    • Support Our Ambassador Program
    • Youth Ambassador Program
    • Prevention Resource Center Locator
  • Events
    • Annual Prevention Advocacy Day – April 18, 2023
    • Prom
    • Speak Hard Youth Conference | April 13, 2023
    • National Drug Facts Week | March 21 – 27, 2022
    • ACT Missouri Opiate Summit
    • Red Ribbon Week
    • Art of Prevention Contest!
  • SADD
    • saddtownhall
    • Prom
    • TST
    • SADD Programs
    • SADD in 60
Home | Prescription Drug Disposal

Missouri State Rep. Holly Rehder Honored for Ongoing Efforts to Fight Prescription Drug Abuse

Award Hosted by ACT Missouri, Charleston C2000 Coalition, FCC Behavioral Health and Mallinckrodt Pharmaceuticals

group

Charleston, Mo., Sept. 7, 2016 – State and community leaders announced today a special honor for Rep. Holly Rehder, R-Sikeston, recognizing her leadership in the fight against prescription drug abuse in Missouri. She was presented with this honor during ceremonies at the C.F. Bowden Center in Charleston.

award-presentation-hand-shake

ACT Missouri, Charleston C2000 Coalition, FCC Behavioral Health and Mallinckrodt Pharmaceuticals came together to highlight Rehder’s unyielding commitment to create a statewide prescription drug monitoring program (PDMP) in Missouri. A PDMP would help prevent drug abuse by providing health care providers timely data for the treatment of patients. In addition, the PDMP program would help identify illicit activities such as visits to multiple doctors for multiple, duplicate prescriptions, something called “doctor shopping.”

fcc-shawn-again law-enforcement-pharmacist llester-g-too

‘It’s an honor to receive this award from those who are truly in the trenches daily fighting to prevent opioid misuse and abuse. It takes all of us working together to keep our communities safe. Mallinckrodt, as well as every organization represented here today, not only helps on the front lines but also in the halls of the Capitol as well. I cannot thank them enough,” said Rep. Rehder.

Missouri is the only state without a PDMP. Each of these organizations strongly supports Rep. Rehder’s position and urges the full Missouri legislature to swiftly pass this important legislation to reduce prescription drug abuse and misuse in the state.

half-holly-and-pouch

Rehder also was recognized for her leadership in advancing the “Safe Communities” program and for her focus on prescription opioid abuse and heroin prevention, which includes her support for the ACT Missouri initiative to distribute 35,000 drug deactivation and disposal pouches donated by Mallinckrodt for citizens – at no cost to them – in the greater Charleston, Mo., area.

“Representative Rehder has been a strong voice for drug abuse prevention in Missouri,” said Jessica Howard, Prevention Program Director, FCC Behavioral Health. “She is an advocate in her community and shares her story about how prescription drug abuse has affected her family, while working hard to prevent other families from suffering this experience.”

Pouches Can Prevent 525,000 Pills from Abuse in Southeast Missouri

The user-friendly pouches are a safe and responsible way to dispose of leftover prescription pain medications. The pouches deactivate prescription drugs and render chemical compounds safe for landfills. After placing pills in the specially formulated pouch and filling it with regular tap water, it can be sealed and thrown away with the household trash. If all 35,000 pouches are filled to the maximum 15 pills capacity, 525,000 prescription pills would be destroyed and prevented from falling into the wrong hands.

natalie-and-mallinckrodt

The drug deactivation and disposal pouches are being distributed through the Missouri Substance Abuse Prevention Network. ACT Missouri facilitates this group of prevention leaders representing 160 community coalitions across the state. These coalitions work with groups such as educators, pharmacies, law enforcement and mental health providers to distribute the pouches.

The organizations that honored Rehder all share a strong commitment to drug abuse prevention – ACT Missouri is a private not-for-profit corporation that works with community groups across the state and national organizations to promote safe, healthy and drug-free communities; the Charleston C2000 Coalition concentrates on youth substance prevention and positive life choices in Charleston, Mo.; FCC Behavioral Health is a private, non-profit community health center that offers an array of behavioral health programs through 22 clinics and treatment centers in Southern Missouri: and Mallinckrodt Pharmaceuticals, a leading global specialty pharmaceutical company, is committed to working with policy makers, community leaders, law enforcement and industry partners to ensure the responsible use of pain medication and prevent unused medications from ending up in the wrong hands.

The local donation is part of Mallinckrodt’s 1-million pouch donation initiative to help combat the abuse of prescription pain medications, which is one of the top public health threats in the U.S. today. A national survey of U.S. adults who used opioids showed that nearly 6 out of 10 had or expect to have leftover opioids, according to findings published online June 13, 2016, in the JAMA Internal Medicine journal. Nearly 68 percent of those who used prescription pain relievers non-medically in 2012-2013 got them from friends or relatives, according to the 2013 Substance Abuse and Mental Health Services Administration (SAMHSA) National Survey on Drug Use and Health. Find more information at www.mallinckrodt.com/disposal.

holly-and-mallenckrodt
“As a company focused on the health and well-being of our patients and communities, Mallinckrodt has long been a strong advocate of addressing the complex issues of opioid misuse and abuse that cause so much harm to families,“ said Mark Trudeau, Mallinckrodt President and Chief Executive Officer. “We share the concerns of people across the nation, and believe that providing patients with a safe and responsible way to dispose of unused medications is critical in this fight against prescription drug abuse.”

The drug deactivation pouches are manufactured by Minneapolis-based Verde Technologies. Find more information at www.mallinckrodt.com/disposal.

CONTACTS
Jessica Howard, MACSAPP, Prevention Program Director
Division of Behavioral Health Funded Regional Support Center
FCC Behavioral Health
C2000@fccinc.org 573-888-5925, ext. 1315

Rhonda Sciarra
Senior Manager, Communications
Mallinckrodt Pharmaceuticals
rhonda.sciarra@mallinckrodt.com
314-654-8618

Mallinckrodt Donates 250,000 Drug Deactivation Systems to ACT Missouri to Support Fight Against Prescription Drug Abuse

Mallinckrodt Donates 250,000 Drug Deactivation Systems to ACT Missouri to Support Fight Against Prescription Drug Abuse
– Company’s Statewide Collaboration Enables Safe Disposal of Unused Medication for Missouri Families –

ST. LOUIS, May 23, 2016 /PRNewswire/ — Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced that it has purchased and donated 250,000 drug deactivation systems to ACT Missouri to provide patients and caregivers a secure, convenient, and environmentally safe way to dispose of unused medications.
The pouch-based systems deactivate prescription drugs and render chemical compounds safe for landfills. They will be distributed through the Missouri Substance Abuse Prevention Network; ACT Missouri facilitates this group of prevention leaders representing 160 community coalitions across the state. Coalitions will work with groups such as educators, pharmacies, law enforcement and mental health providers to distribute the systems.
“With Mallinckrodt’s support, we can further our mission to serve as the statewide prevention catalyst, empowering individuals and fostering partnerships to promote safe, healthy, and drug-free communities,” said Chuck Daugherty, Executive Director of ACT Missouri. “This partnership will help ensure the safe use and proper disposal of prescription medications for Missouri families.”
Today, prescription drug abuse is the fastest-growing U.S. drug problem, according to the U.S. Centers for Disease Control and Prevention. Reports indicate that 72 percent of patients who were prescribed opioids had leftover amounts,1 and more than 70 percent of those who abused prescription pain relievers got them from friends or relatives.
“As a company that is focused on patients, Mallinckrodt is dedicated to providing safe and effective medications for treatment of pain, and is equally committed to working with policy makers, community leaders, law enforcement and industry partners to address the complex issues of opioid addiction and abuse,” said Mark Trudeau, President and Chief Executive Officer of Mallinckrodt. ”We all play an important role in ensuring responsible use of pain medication. This partnership with ACT Missouri illustrates how working together can help prevent unused medications from ending up in the wrong hands.” ACT Missouri is a private not-for-profit established to reduce substance abuse throughout the state. ACT Missouri houses the Statewide Training and Resource Center to help community groups improve strategies to keep youth drug-free as well as offers prevention education and awareness, public policy and advocacy support, media campaign and fiscal management consultation.
Mallinckrodt collaborates with policy champions and community leaders who share its goal of building public awareness of the critical role of responsible drug disposal in the fight against prescription drug abuse. The company has also strongly advocated for a prescription drug monitoring program (PDMP) in Missouri, which remains the lone state without such a program. An integral part of Mallinckrodt’s long-term vision is to invest in and expand the use of opioid abuse-deterrent technology. The company supports development of tamper-resistant/abuse-deterrent technologies and regulatory standards that support the adoption of these technologies.

Other elements of a comprehensive effort to address opioid abuse and misuse include:
• Improving integration of federal and state PDMPs and efforts;
• Developing and sharing best practices for monitoring suspicious orders, both at the manufacturing and supply chain stages – an area where Mallinckrodt is an industry leader;
• Improving stakeholder education for patients, providers and the public at large, including education initiatives validated by measurable outcomes; and
• Enhancing drug take-back and addiction rehabilitation programs.
Mallinckrodt has made past donations of 200,000-plus pouches to organizations such as The Jed Foundation and CADCA (Community Anti-Drug Coalitions of America). These deactivation systems are manufactured by Minneapolis-based Verde Technologies.
ABOUT MALLINCKRODT
Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies, as well as nuclear imaging products. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology and pulmonology; immunotherapy and neonatal respiratory critical care therapies; analgesics and hemostasis products; and central nervous system drugs. The company’s core strengths include the acquisition and management of highly regulated raw materials and specialized chemistry, formulation and manufacturing capabilities. The company’s Specialty Brands segment includes branded medicines; its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing; and the Nuclear Imaging segment includes nuclear imaging agents. To learn more about Mallinckrodt, visit www.mallinckrodt.com.

Mallinckrodt uses its website as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. It also uses its website to expedite public access to time-critical information regarding the company in advance of or in lieu of distributing a press release or a filing with the U.S. Securities and Exchange Commission (SEC) disclosing the same information. Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. Visitors to the website can also register to receive automatic e-mail and other notifications alerting them when new information is made available on the Investor Relations page of the website.

CONTACTS
Media
Rhonda Sciarra
Senior Communications Manager
314-654-8618
rhonda.sciarra@mallinckrodt.com

Meredith Fischer
Senior Vice President, Communications and Public Affairs
314-654-3318
meredith.fischer@mallinckrodt.com
Government Affairs
Mark Tyndall
Vice President, Government Affairs
202-383-0090
mark.tyndall@mallinckrodt.com

Investor Relations
Coleman N. Lannum, CFA Senior Vice President, Investor Strategy and IRO
314-654-6649
cole.lannum@mallinckrodt.com

1 Morbidity and Mortality Weekly Report. Vol. 59, No. 6, United States Centers for Disease Control and Prevention, Feb 19, 2010.
2 2009 National Survey on Drug Use and Health (NSDUH): National Findings, SAMHSA (2010).

Use Spring Break to be Med Wise

Have you talked to your tween or teen about medicine safety lately, or ever?  Spring break may provide a perfect opportunity.  While they are enjoying sleeping late, homework-less evenings, warmer days filled with springtime allergens, or perhaps for some, being left at home without supervision for the first time, pick a time and initiate a discussion!  Your middle schooler may have had some exposure and education on prescription drug safety, but have they learned the potential dangers of medications that are sold over-the-counter (OTC)? Is it really important to teach them to read drug labels or understand proper dosing?

About 50% of children begin self-administering medicines at the age of 11, or 5-6th grade, and over the course of the next 5 years, 90% of them will self-medicate with OTC drugs.  Taken according to the directions, these medications are very useful and healthy.  The opposite also holds true, in fact OTC medicine mistakes attribute to over 10,000 ER visits by kids under 18 each year.  By raising awareness now, the chances of your teen taking more than the recommended dose, or using medications for unintended purposes, can be drastically curbed.

1 in 25 teens report abusing DXM (Dextromethorphan), a common ingredient found in over 100 OTC cold and cough medicines.  Without the proper education, your child or student may be influenced by their peers to misuse it too.

Infographic-page-001

OTC Literacy was developed by Scholastic, the American Association of Poison Control Centers, and McNeil Consumer Healthcare.  Check out the amazing FREE resources for teachers, families, school nurses and communities.   Boy Scouts can earn a patch for their medicine safety efforts as well!

Share your Med Wise experiences, lessons and photos with us on social media!

Deterra Drug Deactivation System

A new cost-effective, easy to use method of disposing of prescription drugs will soon be available in Missouri. ACT Missouri and the Substance Abuse Prevention Network are providing the Deterra Drug Deactivation System to ten Regional Support Centers across Missouri.

In 2014, Missouri collected over 33,000 pounds of prescription medications through take-back events and permanent drop boxes. Each year this amount increases, and there is a concern that if these events do not continue, there will be a significant increase in medications available in homes that could lead to abuse. There is also the concern that people will return to disposing of these medications in ways that are unsafe. According to the 2014 Missouri Student Survey, 28.6% of students though it was very easy or sort of easy to obtain prescription drugs.
Source

“Prescription drug abuse is a real problem in Missouri,” said Natalie Newville, Public Information Officer for ACT Missouri.  “One way to help curb that issue is offering free, easy, safe disposable to local communities. It is our hope that the Deterra Drug Deactivation System is one tool that local communities can use to assist in lowering the percentage of people abusing prescription drugs.”

 

 

#####

For 23 years, ACT Missouri has been serving as the statewide prevention catalyst, empowering individuals and fostering partnership to promote safe, healthy, and drug-free communities. We believe in healthy individuals, healthy communities, and a healthy Missouri. Resources are available to communities by contacting us at info@actmissouri.org.

 

Contact Information:

 

Natalie Newville

Public Information Officer

ACT Missouri

428 E. Capitol Avenue

Jefferson City, MO  65101

(573) 635-6669

nnewville@actmissouri.org

Stay Connected

Get ACT Missouri emails and updates, so you know what's going on. Sign Up
  • Email
  • Facebook

Info For Our

  • Prevention Resource Centers
  • Caring Adults
  • Youth
  • Educators

ACT Missouri Blog

Dec 06

Prevention Happened Here!

Dec 03

National Drug Take Back Totals

May 26

Prevention Wins Were Lean in 2019

Contact Us

2208 Missouri Blvd. Ste. 102 #122
Jefferson City, MO 65109
phone: (817) 832-8559
email: info@actmissouri.org

Prevention Resource Center Locator

Contact your local Prevention Resource Center to find out more about what’s going on in your community and how you can make a difference!
Get a map or see list of locations

Partners

  • Students Against Destructive Decisions (SADD)
  • Missouri Youth/Adult Alliance
  • Partnership for Drug-Free Kids

Important Info

  • About ACT Missouri
  • How To Get Involved
  • Mission, Vision, and Ways We Can Help
  • Programs, Partnerships, and Alliances
  • Disclosure

Privacy Policy

2016 © ACT Missouri